Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) saw some unusual options trading on Wednesday. Investors bought 36,233 call options on the company. This represents an increase of 43% compared to the typical volume of 25,327 call options.

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 3,897 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $29,188.53. Following the transaction, the insider owned 27,175 shares of the company’s stock, valued at $203,540.75. This represents a 12.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Adam C. Vandervoort sold 5,720 shares of the stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $7.49, for a total value of $42,842.80. Following the completion of the transaction, the insider owned 80,732 shares in the company, valued at approximately $604,682.68. The trade was a 6.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 33,288 shares of company stock valued at $251,684. 0.58% of the stock is owned by insiders.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Teladoc Health by 4.2% during the 3rd quarter. Vanguard Group Inc. now owns 21,910,950 shares of the health services provider’s stock worth $169,372,000 after acquiring an additional 891,732 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Teladoc Health by 23.8% in the third quarter. Dimensional Fund Advisors LP now owns 6,889,194 shares of the health services provider’s stock valued at $53,260,000 after purchasing an additional 1,325,106 shares in the last quarter. Geode Capital Management LLC lifted its position in Teladoc Health by 2.1% during the 2nd quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider’s stock worth $36,153,000 after buying an additional 84,356 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Teladoc Health by 11.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,284,697 shares of the health services provider’s stock valued at $17,661,000 after acquiring an additional 227,385 shares in the last quarter. Finally, Allianz Asset Management GmbH boosted its position in Teladoc Health by 189.2% during the third quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock valued at $12,518,000 after purchasing an additional 1,059,458 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on TDOC. Barclays began coverage on shares of Teladoc Health in a research report on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 target price on the stock. BMO Capital Markets began coverage on Teladoc Health in a research report on Thursday, November 13th. They set a “market perform” rating and a $8.00 target price on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. Evercore ISI dropped their target price on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a report on Thursday, October 30th. Finally, Bank of America cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Tuesday, November 25th. Five research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $9.50.

Teladoc Health Price Performance

Shares of TDOC traded up $0.09 during mid-day trading on Wednesday, hitting $6.16. 3,097,451 shares of the company traded hands, compared to its average volume of 5,941,209. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $1.09 billion, a price-to-earnings ratio of -4.82 and a beta of 2.04. The business has a 50-day moving average of $7.21 and a 200 day moving average of $7.72. Teladoc Health has a one year low of $6.03 and a one year high of $15.21.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.26) by $0.05. The firm had revenue of $626.44 million during the quarter, compared to analysts’ expectations of $625.66 million. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The company’s quarterly revenue was down 2.2% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. As a group, equities analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.